NO177995C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater

Info

Publication number
NO177995C
NO177995C NO912298A NO912298A NO177995C NO 177995 C NO177995 C NO 177995C NO 912298 A NO912298 A NO 912298A NO 912298 A NO912298 A NO 912298A NO 177995 C NO177995 C NO 177995C
Authority
NO
Norway
Prior art keywords
methyl
general formula
group
preparation
therapeutically active
Prior art date
Application number
NO912298A
Other languages
English (en)
Other versions
NO177995B (no
NO912298L (no
NO912298D0 (no
Inventor
Bernard Raizon
Yannick Evanno
Odette Legalloudec
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9007483A external-priority patent/FR2663330B1/fr
Priority claimed from FR9104578A external-priority patent/FR2675143B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO912298D0 publication Critical patent/NO912298D0/no
Publication of NO912298L publication Critical patent/NO912298L/no
Publication of NO177995B publication Critical patent/NO177995B/no
Publication of NO177995C publication Critical patent/NO177995C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
NO912298A 1990-06-15 1991-06-14 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater NO177995C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007483A FR2663330B1 (fr) 1990-06-15 1990-06-15 0derives de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, leur preparation et leur application en therapeutique.
FR9104578A FR2675143B3 (fr) 1991-04-15 1991-04-15 Derives de 2-(aminoalkyl)-5-naphtyl-1,3-dioxanes, leur preparation et leur application en therapeutique.

Publications (4)

Publication Number Publication Date
NO912298D0 NO912298D0 (no) 1991-06-14
NO912298L NO912298L (no) 1991-12-16
NO177995B NO177995B (no) 1995-09-25
NO177995C true NO177995C (no) 1996-01-03

Family

ID=26228078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912298A NO177995C (no) 1990-06-15 1991-06-14 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater

Country Status (20)

Country Link
US (1) US5192797A (no)
EP (1) EP0461958B1 (no)
JP (1) JPH0813808B2 (no)
KR (1) KR920000744A (no)
AT (1) ATE111460T1 (no)
AU (1) AU643290B2 (no)
CA (1) CA2044699A1 (no)
CZ (1) CZ280084B6 (no)
DE (1) DE69103968T2 (no)
DK (1) DK0461958T3 (no)
ES (1) ES2064057T3 (no)
FI (1) FI912888A (no)
HU (1) HU208432B (no)
IE (1) IE65067B1 (no)
IL (1) IL98454A (no)
NO (1) NO177995C (no)
NZ (1) NZ238557A (no)
PL (1) PL164840B1 (no)
PT (1) PT97991B (no)
SK (1) SK278142B6 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714056B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane, leur préparation et leur application en thérapeutique.
FR2714055B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique.
FR2714058B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 1,3-dioxane trisubstitués, leur préparation et leur application en thérapeutique.
FR2720939B1 (fr) 1994-06-08 1996-07-12 Synthelabo Utilisation de dérivés de N-[[5-(naphtalén-1-yl)-1,3-dioxan-2-yl]alkyl] acétamide pour la préparation de médicaments utiles dans le traitement des désordres neurodégénératifs.
FR2742152B1 (fr) * 1995-12-06 1998-01-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
KR20010013435A (ko) * 1997-06-05 2001-02-26 고든 라이트 5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
FR2764287B1 (fr) * 1997-06-05 1999-07-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2843964B1 (fr) * 2002-08-29 2004-10-01 Sanofi Synthelabo Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
EP1604654A1 (en) * 2004-05-18 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating dyskinesia
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
TW201014822A (en) 2008-07-09 2010-04-16 Sanofi Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1554878A (no) * 1967-12-12 1969-01-24
US4116670A (en) * 1977-04-04 1978-09-26 Velsicol Chemical Company Dioxane substituted amides
US4097491A (en) * 1977-06-10 1978-06-27 Velsicol Chemical Corporation N-Dialkoxyalkyl-N-dioxanalkylene-α-haloalkanamides

Also Published As

Publication number Publication date
FI912888A (fi) 1991-12-16
ATE111460T1 (de) 1994-09-15
EP0461958A1 (fr) 1991-12-18
PL164840B1 (pl) 1994-10-31
ES2064057T3 (es) 1995-01-16
KR920000744A (ko) 1992-01-29
NO177995B (no) 1995-09-25
AU7843391A (en) 1991-12-19
IE912045A1 (en) 1991-12-18
FI912888A0 (fi) 1991-06-14
HU911992D0 (en) 1991-12-30
SK278142B6 (en) 1996-02-07
PT97991B (pt) 1998-11-30
IL98454A (en) 1996-07-23
DE69103968T2 (de) 1995-03-23
NO912298L (no) 1991-12-16
PT97991A (pt) 1992-03-31
IE65067B1 (en) 1995-10-04
DK0461958T3 (da) 1995-02-20
HUT59124A (en) 1992-04-28
EP0461958B1 (fr) 1994-09-14
DE69103968D1 (de) 1994-10-20
NZ238557A (en) 1992-04-28
US5192797A (en) 1993-03-09
CS183791A3 (en) 1992-01-15
NO912298D0 (no) 1991-06-14
JPH04230277A (ja) 1992-08-19
CA2044699A1 (en) 1991-12-16
CZ280084B6 (cs) 1995-10-18
PL290676A1 (en) 1991-12-16
HU208432B (en) 1993-10-28
JPH0813808B2 (ja) 1996-02-14
IL98454A0 (en) 1992-07-15
AU643290B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
MX9306831A (es) Nuevos compuestos heterociclicos.
SE7712693L (sv) Organiska foreningar
DK71780A (da) Fremgangsmaade til fremstilling af difenylhydantoinderivater
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
NO172437C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser
NO890440D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ATE204278T1 (de) Serotoninergische ergolin derivate
ES2064941T3 (es) Nuevas acil-benzoxazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2118343T3 (es) Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
KR900009640A (ko) 벤족 사제핀 유도체
SE8903312L (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
ATE76398T1 (de) 4-amino-1-trifluoromethyl-tetralin-derivate, deren herstellung und deren therapeutische verwendung.
DE3370627D1 (de) Acridanone derivatives
KR910021373A (ko) 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제
ATE36536T1 (de) Phosphoroimidate.